158 related articles for article (PubMed ID: 29228234)
1. Tgfbr2 inactivation facilitates cellular plasticity and development of Pten-null prostate cancer.
Zhao W; Zhu Q; Tan P; Ajibade A; Long T; Long W; Li Q; Liu P; Ning B; Wang HY; Wang RF
J Mol Cell Biol; 2018 Aug; 10(4):316-330. PubMed ID: 29228234
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo.
Yu M; Trobridge P; Wang Y; Kanngurn S; Morris SM; Knoblaugh S; Grady WM
Oncogene; 2014 Mar; 33(12):1538-47. PubMed ID: 23604118
[TBL] [Abstract][Full Text] [Related]
3. Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
Ai J; Pascal LE; O'Malley KJ; Dar JA; Isharwal S; Qiao Z; Ren B; Rigatti LH; Dhir R; Xiao W; Nelson JB; Wang Z
Oncogene; 2014 May; 33(18):2286-94. PubMed ID: 23708662
[TBL] [Abstract][Full Text] [Related]
4. TGFβ signaling limits lineage plasticity in prostate cancer.
Hao Y; Bjerke GA; Pietrzak K; Melhuish TA; Han Y; Turner SD; Frierson HF; Wotton D
PLoS Genet; 2018 May; 14(5):e1007409. PubMed ID: 29782499
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
Bjerke GA; Pietrzak K; Melhuish TA; Frierson HF; Paschal BM; Wotton D
PLoS One; 2014; 9(3):e92800. PubMed ID: 24651496
[TBL] [Abstract][Full Text] [Related]
6. Opposing roles of TGFβ and BMP signaling in prostate cancer development.
Lu X; Jin EJ; Cheng X; Feng S; Shang X; Deng P; Jiang S; Chang Q; Rahmy S; Chaudhary S; Lu X; Zhao R; Wang YA; DePinho RA
Genes Dev; 2017 Dec; 31(23-24):2337-2342. PubMed ID: 29352019
[TBL] [Abstract][Full Text] [Related]
7. An in vitro system to characterize prostate cancer progression identified signaling required for self-renewal.
Salah M; Nishimoto Y; Kohno S; Kondoh A; Kitajima S; Muranaka H; Nishiuchi T; Ibrahim A; Yoshida A; Takahashi C
Mol Carcinog; 2016 Dec; 55(12):1974-1989. PubMed ID: 26621780
[TBL] [Abstract][Full Text] [Related]
8. TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.
Morris SM; Carter KT; Baek JY; Koszarek A; Yeh MM; Knoblaugh SE; Grady WM
Oncogene; 2015 Jun; 34(25):3273-82. PubMed ID: 25132272
[TBL] [Abstract][Full Text] [Related]
9. Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis.
Bjerke GA; Yang CS; Frierson HF; Paschal BM; Wotton D
Oncogene; 2014 Jul; 33(28):3660-7. PubMed ID: 23995785
[TBL] [Abstract][Full Text] [Related]
10. COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis.
Qin J; Wu SP; Creighton CJ; Dai F; Xie X; Cheng CM; Frolov A; Ayala G; Lin X; Feng XH; Ittmann MM; Tsai SJ; Tsai MJ; Tsai SY
Nature; 2013 Jan; 493(7431):236-40. PubMed ID: 23201680
[TBL] [Abstract][Full Text] [Related]
11. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
[TBL] [Abstract][Full Text] [Related]
12. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
[TBL] [Abstract][Full Text] [Related]
13. Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma.
Mu X; Pradere JP; Affò S; Dapito DH; Friedman R; Lefkovitch JH; Schwabe RF
Gastroenterology; 2016 Mar; 150(3):720-33. PubMed ID: 26627606
[TBL] [Abstract][Full Text] [Related]
14. A basal-enriched microRNA is required for prostate tumorigenesis in a Pten knockout mouse model.
Fan X; Bjerke GA; Riemondy K; Wang L; Yi R
Mol Carcinog; 2019 Dec; 58(12):2241-2253. PubMed ID: 31512783
[TBL] [Abstract][Full Text] [Related]
15. MEX3D is an oncogenic driver in prostate cancer.
Shao L; Wang J; Karatas O; Ittmann M
Prostate; 2021 Nov; 81(15):1202-1213. PubMed ID: 34455614
[TBL] [Abstract][Full Text] [Related]
16. PTEN-knockout regulates metabolic rewiring and epigenetic reprogramming in prostate cancer and chemoprevention by triterpenoid ursolic acid.
Wang L; Wang C; Sarwar MS; Chou P; Wang Y; Su X; Kong AT
FASEB J; 2022 Nov; 36(11):e22626. PubMed ID: 36305462
[TBL] [Abstract][Full Text] [Related]
17. A reciprocal role of prostate cancer on stromal DNA damage.
Banerjee J; Mishra R; Li X; Jackson RS; Sharma A; Bhowmick NA
Oncogene; 2014 Oct; 33(41):4924-31. PubMed ID: 24141771
[TBL] [Abstract][Full Text] [Related]
18. Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.
Alioui A; Dufour J; Leoni V; Loregger A; Moeton M; Iuliano L; Zerbinati C; Septier A; Val P; Fouache A; Russo V; Volle DH; Lobaccaro JA; Zelcer N; Baron S
Nat Commun; 2017 Sep; 8(1):445. PubMed ID: 28874658
[TBL] [Abstract][Full Text] [Related]
19. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z
PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230
[TBL] [Abstract][Full Text] [Related]
20. Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.
Meng X; Vander Ark A; Daft P; Woodford E; Wang J; Madaj Z; Li X
Cancer Lett; 2018 Apr; 418():109-118. PubMed ID: 29337106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
